5.49 USD
↗ 0.00 (0.00%)PRE MARKET (AS OF 07:22 PM EDT)
Atossa Therapeutics, Inc. Common Stock
ATOSNASDAQ • USD
Market: OPEN
Open?$5.68
High?$5.79
Low?$5.39
Prev. Close?$5.45
Volume?36.2K
Avg. Volume?66.0K
VWAP?$5.55
Rel. Volume?0.55x
Bid / Ask
Bid?$4.61 × 100
Ask?$6.59 × 100
Spread?$1.98
Midpoint?$5.60
Valuation & Ratios
Market Cap?46.9M
Shares Out?8.6M
Float?7.7M
Float %?89.2%
P/E Ratio?N/A
P/B Ratio?1.19
EPS?-$4.04
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?5.51Strong
Quick Ratio?5.14Strong
Cash Ratio?5.00Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?N/A▾
P/B?1.19CHEAP▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.2CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-88.4%WEAK▾
ROA?-73.0%WEAK▾
Cash Flow & Enterprise
FCF?$-29785000
Enterprise Value?$5.6M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.
Employees
14
Market Cap
49.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2012-11-08
Address
1448 NW MARKET STREET
SEATTLE, WA 98107
Phone: 206.588.0256
SEATTLE, WA 98107
Phone: 206.588.0256